Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Virology|August 28, 2015
Inactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial CellsNoemi Cavaletto, Anna Luganini, Giorgio Gribaudo
Molecules (Basel, Switzerland)|December 11, 2022
Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type ProanthocyanidinsMassimo E Maffei, Cristiano Salata, Giorgio Gribaudo
Frontiers in Microbiology|June 1, 2016
Bioactive Molecules Released From Cells Infected with the Human CytomegalovirusAnna Luganini, Maria E Terlizzi, Giorgio Gribaudo
Pharmacology & Therapeutics|June 5, 2003
The human cytomegalovirusSanto Landolfo, Marisa Gariglio, Giorgio Gribaudo, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entryAnna Luganini, Patrizia Caposio, Santo Landolfo, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2014
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 proteinBeatrice Mercorelli, Giorgio Gribaudo, Giorgio Palù, et al.
Antiviral Research|February 12, 2025
DHODH inhibitors: What will it take to get them into the clinic as antivirals?Anna Luganini, Donatella Boschi, Marco L Lolli, et al.
The Journal of General Virology|May 29, 2003
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cellsGiorgio Gribaudo, Ludovica Riera, Patrizia Caposio, et al.
Pageof 7